Marianne De Backer has been a strategic advisor, scientist, business unit director, deal maker and corporate investor at the world’s largest healthcare company (Johnson & Johnson (J&J); >70 Bn USD revenue) for more than two decades. Her deep subject matter expertise and experience forging partnerships with leading researchers and executives have led to (launched) breakthroughs in medicine and the development of new models for conducting business. She works across an extensive external network of pharmaceutical, biotech, academic, venture, NGO and government partners in United States, Europe, and beyond, bringing this diversity in perspective as she fosters alliances to improve the health of patients worldwide. In her current role in JJDC, the venture arm of J&J, she is responsible for initiating and managing equity investments to drive business innovation and deliver new and sustainable business to J&J. At J&J, Dr. De Backer has had an impressive career path, transitioning from the lab bench to supporting innovative technology licensing to leading a 50 FTE commercial business unit to serving on the frontlines of late-stage pharmaceutical deal-making.
Marianne is attending / has attended:
Venture Summit | West 2018
Venture Summit | West 2017